United States Nuclear Regulatory Commission - Protecting People and the Environment

Escalated Enforcement Actions Issued to Materials Licensees - O

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

This table includes a collection of significant enforcement actions (referred to as "escalated") that the NRC has issued to materials licensees.

The types of actions and their abbreviations are as follows:

  • Notice of Violation for Severity Level I, II, or III violations (NOV)
  • Notice of Violation and Proposed Imposition of Civil Penalty (NOVCP)
  • Order Imposing Civil Penalty (CPORDER)
  • Order Modifying, Suspending, or Revoking License (ORDER)

This page includes links to files in non-HTML format. See Plugins, Viewers, and Other Tools for more information.

Licensee Name and
NRC Action Number
Action Type
(Severity) &
Civil Penalty
(if any
Date Description
Oakwood Hospital - Annapolis Center, MI
EA-11-010
NOV
(SL III)
03/04/2011 On March 4, 2011, the NRC issued a Notice of Violation to Oakwood Hospital – Annapolis Center for a Severity Level III problem involving: (1) the licensee's usage of a dose that differed from the prescribed dose by more than 20 percent which is contrary to 10 CFR 35.63(d); and (2) the failure to verify that the assayed dosage was within 10 percent of the prescribed activity as required by License Condition 15.A. Specifically, the licensee administered approximately 124.5 millicuries of sodium pertechnetate technetium-99m (Tc-99m) to a patient instead of the prescribed dosage of 10 millicuries of Tc-99m tetrofosmin, a difference in excess of 20 percent. The licensee failed to verify that it had the correct syringe which resulted in the incorrect radiopharmaceutical and dosage being administered to the patient.
Ohio State University (The), OH
EA-99-175
NOV
(SL III)
10/07/1999 Violation involving the release of a patient who had been administered radiopharmaceuticals without ensuring that the total effective dose equivalent to any other individual exposed to the patient was below required limits.
Ohio State University (The), OH
EA-97-258
NOVCP
(SL II)

$13,000
10/23/1997 Willful failure to conduct inventories and dispose of waste. Breakdown in control of licensed program.
Ohio Valley Medical Center, OH
EA-09-182
NOV
(SL III)
9/17/2009 On September 17, 2009, the NRC issued a Notice of Violation to Ohio Valley Medical Center for a Severity Level III violation involving the failure to meet the physical presence requirements of 10 CFR 35.615(f)(2) during high dose radiation (HDR) treatments. Specifically, on June 17, 2009 and other occasions prior to that date, neither an authorized user (AU), nor a physician under the supervision of an AU and trained in the operation and emergency response for the unit, were physically present during continuation of HDR treatments.
Oklahoma State University, OK
EA-00-203
NOV
(SL III)
12/07/2000 On December 7, 2000, a Notice of Violation was issued for a Severity Level III violation associated with the use of licensed material (tritiated thymadine) in an unapproved and unauthorized location.
Oklahoma, University of, OK
EA-96-049
NOVCP
(SL III)

$ 2,500
06/17/1996 Deliberate failure to secure licensed material.
Omnitron International, TX
EA-96-061
NOV
(SL III)
06/21/1996 Failed to file for reciprocity prior to conducting licensed activities in Oklahoma, a non-agreement state.
Oncology Institute of Greater Lafayette, IN
EA-07-313
NOV
(SL III)
03/31/2008 On March 31, 2008, a Notice of Violation was issued for a Severity Level III problem. The violations involved the failure to instruct an Authorized Medical Physicist, a supervised individual, in the licensee's written directive procedures with respect to the use of byproduct material and failure to develop, implement and maintain written directive procedures to provide high confidence that each administration was in accordance with the written directive. Specifically, the licensee did not verify before treatment that the treatment plan was properly input into the high dose rate remote afterloader unit and did not verify, after treatment, that the step size, a treatment parameter used for the treatments, was in agreement with the treatment plan. A medical event occurred during the licensee's administration of three treatment fractions to a patient. As a result, portions of the treatment site received a total dose that differed from the prescribed dose by more than 20 percent.
Overhoff Technology Corporation, OH
EA-96-242
NOVCP
(SL III)

$ 2,500
04/16/1998 Distribution of quantities in excess of "license" limit.
Withdrawal 08/19/1998
Overlook Hospital, NJ
EA-97-246
NOVCP
(SL III)

$ 2,750
08/21/1997 Deliberate misadministration.
Owensby and Kritikos, Inc., LA
EA-11-100
NOV
(SL III)
06/08/2011 On June 8, 2011, the NRC issued a Notice of Violation to the Owensby and Kritikos, Inc., for a Severity Level III violation involving the licensee's failure to control and maintain constant surveillance of the licensed material in an unrestricted area as required by 10 CFR 20.1801 and 20.1802. Specifically, during inspection on July 29, 2010, the radiography camera was found on the floor of the unlocked darkroom and no radiography personnel were maintaining constant surveillance over the material.
Page Last Reviewed/Updated Tuesday, December 02, 2014